Healthcare Analytics, Population Health Management, Healthcare Big Data

Medical Research

Mount Sinai Creates Imaging Data Warehouse for Precision Medicine

June 20, 2017 - Mount Sinai Health System has created a centralized imaging research warehouse (IRW) able to integrate clinical images with deidentified electronic health record (EHR) data. The project, developed by Mount Sinai’s Translational and Molecular Imaging Institute (TMII) and supported by the National Institute of Health, will allow researchers to access imaging and other clinical data on...


More Articles

Mount Sinai Creates Imaging Data Warehouse for Precision Medicine

by Jennifer Bresnick

Mount Sinai Health System has created a centralized imaging research warehouse (IRW) able to integrate clinical images with deidentified electronic health record (EHR) data. The project, developed by Mount Sinai’s Translational and Molecular...

“All of Us” Precision Medicine Program Enters Beta Testing

by Jennifer Bresnick

The first beta test participants in the All of Us Research Program have started to contribute their personal health data to the nation-wide precision medicine program, says Director Eric Dishman. The program, previously known as the PMI Cohort,...

70% of Orgs Planning Precision Medicine Will Deploy Within 2 Years

by Jennifer Bresnick

Precision medicine is quickly approaching its mainstream tipping point as organizations pursue the benefits of delivering personalized care to patients.  Nearly 70 percent of healthcare organizations that are planning precision medicine...

Artificial Intelligence Could Take Over Surgical Jobs by 2053

by Jennifer Bresnick

Robots are already a familiar sight for surgeons in many operating rooms, but there is a good chance that artificial intelligence will eventually render its human colleagues obsolete.  In a survey of machine learning and AI experts, researchers...

CancerLinQ Partners with FDA for Precision Medicine Studies

by Jennifer Bresnick

CancerLinQ and the FDA have entered a long-term partnership centered on studying the real-world impacts of precision medicine therapies for cancer care.  Using big data analytics and patient data, the two organizations will monitor newly...

New CancerLinQ Partnership Expands Big Data Analytics Platform

by Jennifer Bresnick

The CancerLinQ oncology data repository is steadily expanding its ability to use big data analytics to deliver meaningful clinical decision support to providers at the point of care.  The latest step in its evolution is a newly announced...

Deep Learning Network 100% Accurate at Identifying Breast Cancer

by Jennifer Bresnick

A deep learning network developed at Case Western Reserve University earned a 100 percent accuracy score when identifying the presence of invasive forms of breast cancer in pathology images.  The machine learning tool was consistently more...

FHIR Can Move Genomics from Prediction to Precision Medicine

by Jennifer Bresnick

In just a few short decades, the field of genomics has expanded dramatically, transitioning from a specialized discipline of academic biology into a mainstay of clinical care at academic medical centers, dedicated precision medicine hubs, and...

UVA Gene Mutation Research Method Speeds Precision Medicine

by Jennifer Bresnick

A team from the University of Virginia School of Medicine has developed a quicker way to examine the impact of gene mutation on patient health, potentially changing the way cancer labs conduct research into precision medicine and personalized...

EHRs, Value-Based Care Constrain Personalized Medicine Progress

by Jennifer Bresnick

Oncologists are eager to embrace the potential of personalized medicine and genetically-driven precision therapies, but face many of the technical, administrative, and reimbursement challenges that afflict their peers in other specialties, finds...

ONC Highlights Its Precision Medicine Initiative Collaborations

by Jennifer Bresnick

The Precision Medicine Initiative (PMI) is alive and well at the Office of the National Coordinator, where partnerships with other key government agencies are laying the big data groundwork for more personalized care.  Collaborations with...

AMIA, Dryad Partner for Healthcare Research Big Data Access

by Jennifer Bresnick

The American Medical Informatics Association and the Dryad Digital Repository have announced a new partnership that will expand the availability of healthcare research big data for the validation, repetition, and expansion of published studies....

NIH to Bring Precision Medicine Data Collection to Patient Homes

by Jennifer Bresnick

Thousands of volunteers for the All of Us precision medicine cohort won’t even have to leave the comfort of their living rooms when contributing data to the project thanks to a new NIH collaboration with mobile medical service EMSI. The...

Next-Generation Genomics, Precision Medicine to Top $100B

by Jennifer Bresnick

The markets for next-generation genomic testing tools and precision medicine software and services will be worth more than $100 billion by 2022, according to a new series of market reports, propelled by breakthroughs in cancer care, big data...

Precision Medicine, Population Health Share Strategies and Goals

by Jennifer Bresnick

Any organization that wants to have a hope of functioning smoothly divides its operations into distinct departments, each of which is in charge of a specific process.  Every member of the team contributes to the organization’s ultimate...

Point of Care Diagnostics Usher in Era of Personalized Medicine

by Jennifer Bresnick

Even before the advent of value-based care, healthcare providers have always faced pressure to do more, do it better, and do it faster while using fewer resources and producing high quality results.  As reimbursement changes tighten the...

Cancer Detection Company Gets $900M from Pharma, VC Investors

by Jennifer Bresnick

GRAIL, Inc., a precision medicine and life sciences company aiming to develop new very early detection techniques for cancer, has attracted more than $900 million in investment capital from some of the most well-known names in pharmaceutical...

Are Clinical Trials Diverse Enough to Ensure Patient Safety?

by Thomas Beaton

A new FDA report indicates that clinical trials may not be accurately representing real-world demographic patterns, leading to concerns that new drugs are not being accurately tested for patient safety and effectiveness.  Only 48 percent...

NIH Renames Precision Medicine Cohort, Urges Patient Engagement

by Thomas Beaton

The newly unveiled All of Us Research Program, formally known as the Precision Medicine Initiative (PMI) Cohort, will help the NIH collect diverse patient data and foster patient engagement to support its million-member precision medicine biobank....

NIH Awards $21M to Precision Medicine Epilepsy Collaboration

by Jennifer Bresnick

An international academic research consortium will use precision medicine strategies and a new $21 million grant from the National Institutes of Health to further research into the development and treatment of epilepsy. The collaboration, spearheaded...

Continue to site...